Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B revaccination comparison in prior vaccine non-responders
NL-OMON21963Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Mar 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of Hepatitis B vaccine, Recombivax HB and hepatitis b vaccine recombinant in hepatitis B (HBV) (4 arms), sponsored by National Institute for Public Health and the Environment. Primary endpoints: Superiority of one investigated vaccine, Seroprotection response and 1 more. Started Mar 2012; status: active, not recruiting.
02
Drugs
Hepatitis B vaccineRecombivax HBhepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NL-OMON21963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21963.